Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
AssigneeShionogi & Co., Ltd.
InventorsFumihiko Wantanabe, Hiroshige Tsuzuki, Mitsuaki Ohtani
Life of this patent
Estimating the term…
Abstract
Compounds having a metalloproteinase inhibitory activity, represented by the formula (I), its optically active isomers, their pharmaceutically acceptable salts, or hydrates thereof
Claims18
A composition for inhibiting metalloproteinase which comprises a compound of formula I:
- wherein R1 is optionally substituted heteroarylalkyl;
- R2 is hydrogen atom or optionally substituted lower alkyl;
- R3 is optionally substituted arylene;
- R4 is a bond, —(CH2)m—, —CH═CH— or —C≡C—;
- R5 is optionally substituted aryl;
- Y is —NHOH or —OH;
- and m is 1 or 2;
- provided R2 is hydrogen atom when Y is —NHOH, with the proviso that R5 and R3 together do not form a biphenyl group, and its optically active substance, pharmaceutically acceptable salt, or hydrate thereof.
A composition for inhibiting metalloproteinase which comprises a compound of formula I:
- wherein R1 is optionally substituted heteroarylalkyl;
- R2 is hydrogen atom or optionally substituted lower alkyl;
- R3 is optionally substituted arylene;
- R4 is a bond, —(CH2)m—, —CH═CH— or —C≡C—;
- R5 is optionally substituted aryl;
- Y is —NHOH or —OH;
- and m is 1 or 2;
- provided R2 is hydrogen atom when Y is —NHOH,
- R5 is aryl substituted by lower alkyl or optionally substituted aryl when R4 is a bond,
- with the proviso that R5 and R3 together do not form a biphenyl group, and
- its optically active substance, pharmaceutically acceptable salt, or hydrate thereof.
A compound of the formula I:
- wherein R1 is optionally substituted heteroarylalkyl;
- R2 is hydrogen atom or optionally substituted lower alkyl;
- R3 is optionally substituted arylene;
- R4 is a bond, —(CH2)m—, —CH═CH— or —C≡C—;
- R5 is optionally substituted aryl;
- Y is —NHOH or —OH;
- and m is 1 or 2;
- provided R2 is hydrogen atom when Y is —NHOH,
- R5 is aryl substituted with lower alkyl or optionally substituted aryl when R4 is a bond,
- and R3 is not 1,2-phenylene,
- and its optically active substance, pharmaceutically acceptable salt, or hydrate thereof.
A compound of formula II:
- wherein R6 is —CH═CH— or —C≡C—;
- R7 is optionally substituted aryl;
- R8 and R9 are each independently hydrogen atom, lower alkoxy, or nitro;
- R1 is optionally substituted heteroarylalkyl;[,]
- R2 is hydrogen atom or optionally substituted lower alkyl;
- Y is—NHOH or —OH;
- and
- its optically active substance, pharmaceutically acceptable salt, or hydrate thereof.
A compound of formula III:
- wherein R10 is —(CH2)m—;
- m is 1 or 2;
- R1 is optionally substituted heteroarylalkyl;
- R2 is hydrogen atom or optionally substituted lower alkyl;
- R7 is optionally substituted aryl;
- R8 and R9 are each independently hydrogen atom, lower alkoxy, or nitro;
- Y is—NHOH or —OH;
- and
- its optically active substance, pharmaceutically acceptable salt, or hydrate thereof.
A compound of formula V:
- wherein R12 is —CH═CH— or —C≡C—;
- R1 is optionally substituted heteroarylalkyl;
- R1 is hydrogen atom or optionally substituted lower alkyl;
- R7 is optionally substituted aryl;
- R8 and R9 are each independently hydrogen atom, lower alkoxy or nitro;
- and
- its optically active substance, pharmaceutically acceptable salt, or hydrate thereof.
A compound of formula X:
- wherein R12 is —CH═CH— or —C≡C—;
- R1 is optionally substituted heteroarylalkyl;
- R7 is optionally substituted aryl;
- R8 and R9 are each independently hydrogen atom, lower alkoxy or nitro;
- and
- its optically active substance, pharmaceutically acceptable salt, or hydrate thereof.
A method of inhibiting the activity of a metalloproteinase, comprising administering to a subject in need thereof an effective amount of a compound of formula I:
- wherein R1 is optionally substituted heteroarylalkyl;
- R1 is hydrogen atom or optionally substituted lower alkyl;
- R3 is optionally substituted arylene;
- R4 is a bond, —(CH2)m—, —CH═CH— or —C≡C—;
- R5 is optionally substituted aryl;
- Y is —NHOH or —OH;
- and m is 1 or 2;
- provided R2 is hydrogen atom when Y is —NHOH,
- with the proviso that R5 and R3 together do not form a biphenyl group, and
- its optically active substance, pharmaceutically acceptable salt, or hydrate thereof.
A method of inhibiting the activity of a type-IV collagenase, comprising administering to a subject in need thereof an effective amount of a compound of formula I:
- wherein R1 is or optionally substituted heteroarylalkyl;
- R2 is hydrogen atom or optionally substituted lower alkyl;
- R3 is optionally substituted arylene;
- R4 is a bond, —(CH2)m—, —CH═CH— or —C≡C—;
- R5 is optionally substituted aryl;
- Y is —NHOH or —OH;
- and m is 1 or 2;
- provided R2 is hydrogen atom when Y is —NHOH,
- with the proviso that R5 and R3 together do not form a biphenyl group, and
- its optically active substance, pharmaceutically acceptable salt, or hydrate thereof.
Dependencies are inferred from the claim text.